| |
| |
|
| Insider
Information: |
Tessari Eben |
| Relationship: |
|
| City: |
Hamilton |
| State: |
D0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
126,024 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,467,550 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
126,024 |
|
|
| Total
Value |
$2,467,550 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-04-08 |
126,024 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2024-04-08 |
4 |
D |
$17.90 |
$14,338 |
D/D |
(801) |
126,024 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,726 |
126,825 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2024-04-01 |
4 |
D |
$19.70 |
$10,264 |
D/D |
(521) |
124,099 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,773 |
124,620 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2024-03-01 |
4 |
AS |
$22.03 |
$26,194 |
D/D |
(1,189) |
122,847 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2024-03-01 |
4 |
OE |
$1.59 |
$1,043 |
D/D |
656 |
124,036 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2023-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,964 |
123,957 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2023-09-02 |
4 |
D |
$17.76 |
$10,248 |
D/D |
(577) |
123,380 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2023-09-01 |
4 |
D |
$17.76 |
$14,226 |
D/D |
(801) |
121,993 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,727 |
122,794 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2023-04-10 |
4 |
D |
$10.71 |
$8,579 |
D/D |
(801) |
120,067 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2023-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,727 |
120,868 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2023-03-20 |
4 |
D |
$11.12 |
$9,741 |
D/D |
(876) |
118,141 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2023-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,982 |
119,017 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2023-03-16 |
4 |
D |
$11.46 |
$6,612 |
D/D |
(577) |
116,035 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2023-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,964 |
116,612 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2022-09-02 |
4 |
D |
$11.44 |
$6,601 |
D/D |
(577) |
114,648 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2022-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,964 |
115,225 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2022-07-15 |
4 |
A |
$9.56 |
$10,019 |
D/D |
1,048 |
113,261 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2022-03-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,611 |
113,674 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF OPERATING OFFICER |
• – – |
2022-03-21 |
4 |
D |
$10.98 |
$16,042 |
D/D |
(1,461) |
112,213 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2022-03-16 |
4 |
D |
$10.13 |
$6,899 |
D/D |
(681) |
109,063 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2022-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,964 |
109,744 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2022-01-15 |
4 |
A |
$9.63 |
$9,341 |
D/D |
970 |
107,780 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chief Operating Officer |
• – – |
2021-07-15 |
4 |
A |
$11.49 |
$9,973 |
D/D |
868 |
106,810 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
